Celsus Therapeutics skin cream fails study

February 17, 2015 3:57 PM

3 0

(Reuters) - British drugmaker Celsus Therapeutics Plc's stock plunged as much as 83 percent after the company's skin cream failed the main goal of a mid-stage study.

Celsus chief executive Gur Roshwalb said he was "surprised" by the number of patients who responded to a placebo.

Also read: US stocks hold higher after release of Fed's Beige Book; energy rises 2%

Read more

To category page